Related Experiment Video
Updated: Jun 23, 2026
12:45
Benefits of Cardiac Resynchronization Therapy in an Asynchronous Heart Failure Model Induced by Left Bundle Branch Ablation and Rapid Pacing
Published on: December 11, 2017
[The SCOOP II trial in heart failure]
M C Albanese1, A Bulfoni, P Rossi
1U.O. di Cardiologia, Azienda Ospedaliera S. Maria della Misericordia, Udine, mca@adriacom.it
Summary
This study evaluated a health education intervention for chronic heart failure (CHF) patients. The intervention aimed to improve therapeutic compliance and quality of life, with final results pending.
Area of Science:
- Cardiology
- Public Health
- Nursing Education
Context:
- Chronic heart failure (CHF) patients admitted to Internal Medicine Units exhibit high readmission and mortality rates.
- A significant proportion of CHF patients experience a diminished quality of life.
- Community hospitals face challenges in managing CHF patient outcomes.
Purpose:
- To assess the efficacy of a health education intervention in enhancing therapeutic compliance among CHF patients.
- To determine the impact of the intervention on the quality of life for individuals with chronic heart failure.
- To improve adherence to heart failure management guidelines through a structured educational program.
Summary:
- A randomized controlled trial involving 200 chronic heart failure patients compared a nurse-guided education program with usual care.
- The intervention group received facilitated telephone communication and regular internist follow-ups.
- Primary endpoints included improvements in quality of life, quality of service, and compliance with heart failure guidelines.
Impact:
- The intervention has the potential to reduce hospital readmissions and mortality rates in CHF populations.
- Improved therapeutic compliance can lead to better long-term health outcomes for chronic heart failure patients.
- Enhanced quality of life and service quality are anticipated outcomes for the intervention group.
Related Concept Videos
01:30Heart Failure IV: Classification and Diagnostic Evaluation
Heart failure can be classified in various ways, with the most common classifications based on physical activity limitations, disease progression, severity, and treatment strategies.The Functional Classification of Heart Failure divides patients into four categories based on physical activity limitation due to symptom burden.Class I: Patients in this class have cardiac disease but no physical activity limitations. Ordinary activities like walking, climbing stairs, or routine tasks do not cause...
01:29Heart Failure II: Pathophysiology
Systolic Heart Failure and Compensatory MechanismsSystolic heart failure (also termed HFrEF, Heart Failure with Reduced Ejection Fraction) is the most prevalent type of heart filure. It results in a decreased volume of blood being pumped from the ventricle. The aortic arch and carotid sinuses have baroreceptors that detect reduced blood pressure, triggering the sympathetic nervous system (SNS) to release epinephrine and norepinephrine. Initially, this response aims to boost heart rate and...
01:26Heart Failure Drugs: Inotropic Agents
Positive inotropic agents are commonly used as the first line of treatment for heart failure. One such agent is digoxin, derived from the genus Digitalis, which has been known for centuries but effectively utilized since 1785. However, these cardiac glycosides can have potentially toxic effects due to their mechanism of action, which involves inhibiting Na+/K+-ATPase and increasing contractility. Digoxin is absorbed orally and distributed in various tissues, including the CNS. It has a long...
01:26Heart Failure III: Clinical Manifestations
Heart failure (HF) manifests primarily as dyspnea, fatigue, and fluid retention, resulting in peripheral and pulmonary edema. Symptoms may vary depending on which ventricle is more affected, left or right.Left-Sided Heart FailureAlso known as left ventricular failure, this condition results from the left ventricle's inability to fill or eject sufficient blood into the systemic circulation. It leads to pulmonary congestion, which occurs when the left ventricle fails to eject blood effectively...
01:27Heart Failure I: Introduction
Heart failure refers to a clinical syndrome caused by structural or functional cardiac disorders that prevent the heart from pumping an adequate amount of blood to meet the body's metabolic needs. This condition often arises from myocardial infarction or ischemia, leading to decreased cardiac output, reduced tissue perfusion, impaired gas exchange, fluid volume imbalance, and decreased functional ability.Heart failure can result from disruptions in the mechanisms that regulate cardiac output...
01:30Heart Failure V: Medical Management
Medical Management of Acute Decompensated Heart Failure (ADHF)The primary goals of therapy for patients hospitalized with acute decompensated heart failure (ADHF) include:Relieving symptomsOptimizing volume statusSupporting oxygenation and ventilationMaintaining cardiac output (CO) and end-organ perfusionIdentifying and addressing the cause of ADHFPreventing complicationsProviding patient education on factors precipitating HF exacerbationPlanning for dischargeOngoing monitoring and assessment...